Integrated Dosimetry Software for Azedra I-131 Therapy

被引：0
|
作者：
Sheftman, D. [1 ]
Hintenlang, D. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
MEDICAL PHYSICS | 2022年 / 49卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PO-GePV-I-
引用
收藏
页码：E656 / E657
页数：2
相关论文
共 50 条
  • [21] FAILURE OF PRETREATMENT I-131 RETENTION VALUES TO INFLUENCE THE OUTCOME OF I-131 THERAPY FOR THYROTOXICOSIS
    BEARDWELL, CG
    CHAPMAN, AJ
    SHALET, SM
    JOURNAL OF ENDOCRINOLOGY, 1986, 108 : 186 - 186
  • [22] THE DOSIMETRY OF I-131 LABELED METAIODOBENZYLGUANIDINE IN THE TREATMENT OF MALIGNANT PHEOCHROMOCYTOMAS
    CAREY, JE
    SWANSON, D
    SISSON, JC
    SHAPIRO, B
    MEYERS, LJ
    BEIERWALTES, WH
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P49 - P49
  • [23] Factors influencing the dosimetry and the therapeutic outcome of radioiodine (I-131) therapy of differentiated thyroid cancer
    Behr, TM
    Behe, M
    Gratz, S
    Hüfner, M
    Becker, W
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1004 - 1004
  • [24] The MEDIRAD Multi-national I-131 Dosimetry Study for Thyroid Ablation and Adjuvant Therapy
    Leek, F.
    Gregory, R.
    Newbold, K.
    Verburg, F. A.
    Luster, M.
    Schurrat, T.
    Lassmann, M.
    Eberlein, U.
    Buck, A. K.
    Lapa, C.
    Bardies, M.
    Mora-Ramirez, E.
    Vallot, D.
    Courbon, F.
    Vija, L.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S359 - S360
  • [25] Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma
    Kenneth F. Koral
    John P. Huberty
    Bill Frame
    Katherine K. Matthay
    John M. Maris
    Denise Regan
    Daniel Normolle
    Gregory A. Yanik
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 2105 - 2112
  • [26] Hepatic absorbed radiation dosimetry during I-131 Metaiodobenzylguanadine (MIBG) therapy for refractory neuroblastoma
    Koral, Kenneth F.
    Huberty, John P.
    Frame, Bill
    Matthay, Katherine K.
    Maris, John M.
    Regan, Denise
    Normolle, Daniel
    Yanik, Gregory A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (11) : 2105 - 2112
  • [27] Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy
    Dotinga, Maaike
    Vriens, Dennis
    van Velden, Floris
    Heijmen, Linda
    Nagarajah, James
    Hicks, Rodney
    Kapiteijn, Ellen
    de Geus-Oei, Lioe-Fee
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (03): : 250 - 264
  • [28] Use of Integrated SPECT/CT Imaging for Tumor Dosimetry in I-131 Radioimmunotherapy: A Pilot Patient Study
    Dewaraja, Yuni K.
    Wilderman, Scott J.
    Koral, Kenneth F.
    Kaminski, Mark S.
    Avram, Anca M.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (04) : 417 - 426
  • [29] PATIENT GUIDANCE AFTER I-131 THERAPY
    ODOHERTY, MJ
    KETTLE, AG
    COAKLEY, AJ
    MOUNTFORD, PJ
    LANCET, 1992, 340 (8832): : 1419 - 1419
  • [30] AUTOIMMUNE RESPONSE TO ANTITHYROID AND I-131 THERAPY
    TAKO, J
    BANOS, C
    ENDOKRINOLOGIE, 1971, 57 (03): : 400 - &
12345